This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB08364/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08364/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08364/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08364/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08364
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08364 n12:DB08364
dcterms:title
1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE
adms:identifier
n8:P89 n9:46937144 n10:DB08364 n11:99444835
n3:IUPAC-Name
n4:271B50FC-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5102-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5101-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B50FE-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B50FF-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5100-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B50FA-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B50FB-363D-11E5-9242-09173F13E4C5 n4:271B50F8-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B50F9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5108-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5109-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5103-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5104-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5106-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5105-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5107-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B510E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5110-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5111-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B510D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B510C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B510F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B50FD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B510A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B510B-363D-11E5-9242-09173F13E4C5